May 19, 2020 - ONE to ONE
Nach zwei Monaten Corona-Stresstest: "Die kreativen Herausforderungen kommen erst noch"
Go to article
May 19, 2020 - mmj daily
German MMJ company secures additional funding
Go to article
May 19, 2020 - Gründerszene
Der Cannabismarkt ist doch kein Millionengarant mehr
Go to article
May 11, 2020 - mmj daily
COVID-19 restrictions impact the global supply chain: DEMECAN imports medicinal cannabis from the Netherlands to ensure supply
Go to article
6 May 2020
COVID-19 restrictions impact the global supply chain: DEMECAN imports medicinal cannabis from the Netherlands to ensure supply.

The German medicinal drug market is currently experiencing exceptional circumstances due to the global COVID-19 pandemic. Supply chain […]

March 20, 2020 - Donaukurier
Bayerische Cannabis-Patienten im Nachteil? Hersteller für medizinischen Wirkstoff bisher nur in Nord- und Ostdeutschland – Heuer erste Ernte
Go to article
March 4, 2020 - PZ Pharmazeutische Zeitung
Gesteigerter Bedarf: FDP will 20-mal mehr Cannabis anbauen lassen
Go to article
27 February 2020
DEMECAN signs binding supply agreement with Australia-based medical cannabis producer

DEMECAN announces the signing of a three-year supply agreement with Australian-based medical cannabis producer, Little Green Pharma, marking yet another milestone in DEMECAN’s path to guarantee a consistent supply of pharmaceutical grade cannabis to patients in Germany. The agreement is for an annual amount of at least 1,000 kg of dried flower or 48,000 units […]

24 February 2020
DEMECAN receives approval for the distribution of cannabis flowers from the Netherlands

DEMECAN is pleased to announce receipt of AmRadV approval from the German cannabis agency, marking the start of cannabis flower sales from the Netherlands. The flowers, manufactured by Bedrocan, are sold exclusively for medical purposes through pharmacies. The AmRadV regulates the sale of medicinal products treated with ionizing radiation to protect patients from bacteria, mold, […]

4 October 2019
btov and Single Family Office Invest in German Cannabis: 7 Million Euros for DEMECAN

The btov Private Investor Network and a German Single Family Office invest in DEMECAN DEMECAN is the first German producer of medical cannabis Berlin, October 01, 2019 – DEMECAN has completed a Series A financing round of 7 million euros. The funding will be used to expand the production facility for medical cannabis and the […]